Coya Therapeutics, Inc.

About Coya Therapeutics, Inc.

Coya Therapeutics is a clinical-stage biotechnology company based in Houston, focused on developing proprietary therapies to enhance the function of regulatory T cells (Tregs). The company targets neurodegenerative, autoimmune, and metabolic diseases with multiple Treg therapeutic modalities.

Products & Services

COYA 302:A Treg-enhancing biologic therapy for neurodegenerative and autoimmune diseases.

COYA 201:An allogeneic Treg-derived exosome therapy for targeted disease treatment.

COYA 101:An autologous Treg cell therapy designed for specific therapeutic applications.

Specialties

Regulatory T Cell (Treg) Therapies Neurodegenerative Diseases Autoimmune Diseases Metabolic Diseases Biologics Development

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Private Placement T: - FT: Private Placement	A: 11100000 MR: - FA: 11.1 million FAN: 11100000	D: 2026-01-30 FD: 2026-01-30	2 investors
2	RT: Public Offering T: - FT: Public Offering	A: 23000000 MR: - FA: $23.0 million FAN: 23000000	D: 2025-10-27 FD: 2025-10-27	-
3	RT: Public Offering T: - FT: Public Offering	A: 20000000 MR: - FA: $20.0 million FAN: 20000000	D: 2025-10-24 FD: 2025-10-24	2 investors
4	RT: Private Placement T: - FT: Private Placement	A: 10000000 MR: - FA: 10.0 million FAN: 10000000	D: 2024-10-23 FD: 2024-10-23	1 investors
5	RT: Private Placement T: - FT: Private Placement	A: 10000000 MR: - FA: $10.0 million FAN: 10000000	D: 2024-10-22 FD: 2024-10-22	1 investors
6	RT: Equity T: - FT: Equity	A: 5000000 MR: - FA: $5 million FAN: 5000000	D: 2024-05-20 FD: 2024-05-20	1 investors
7	RT: Private Placement T: - FT: Private Placement	A: 26500000 MR: - FA: 26.5 million FAN: 26500000	D: 2023-12-12 FD: 2023-12-12	2 investors
8	RT: Private Placement T: - FT: Private Placement	A: 26500000 MR: - FA: 26.5 million FAN: 26500000	D: 2023-12-06 FD: 2023-12-06	2 investors
9	RT: Initial Public Offering T: - FT: Initial Public Offering	A: 15250000 MR: - FA: $15.25 million FAN: 15250000	D: 2023-01-03 FD: 2023-01-03	3 investors

Private Placement Latest

2026-01-30

$11.1M

2 investors (Pro only)

Public Offering 2025-10-27

$23.0M

Public Offering 2025-10-24

$20.0M

View 8 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

A

Arun Swaminathan

Chief Executive Officer

F

Fred Grossman

President & Chief Medical Officer

D

David Snyder

Chief Financial Officer & Chief Operating Officer

M

Michelle Frazier

Senior VP of Regulatory

A

Aaron Thome

Head of Neuroinflammation Platform

K

Karen King

Senior VP of Program Management & Clinical Operations

View 16 more team members with Pro

Unlock Full Team Directory

Recent News